Gene expression profiling studies have identified several subtypes of breast cancer (BC) distinguished by the expression of hormone receptor, cell proliferation, and human epidermal growth factor receptor 2 (HER2) genes (1–3). This evidence concerns the gene NR4A1 and breast cancer.